News & Perspective

Feb 07, 2017

Feb 07, 2017

News Scan for Feb 07, 2017

H7N9 case in China
Bacteremia treatment
HPV vaccine endorsement
Zika blood screening

Feb 07, 2014

Feb 07, 2014

News Scan for Feb 07, 2014

MERS case in UAE
Canadian H5N1 gene analysis
N95 respirators and bacterial infections
2014 ACIP recommendations

Feb 01, 2013

Feb 01, 2013

CDC: Pandemic vaccine prevented 1 million cases, 300 deaths

(CIDRAP News) – The influenza vaccine that was developed to fight the 2009 pandemic saved roughly 300 lives and prevented about 1 million illnesses and 6,000 hospitalizations, or under 3% of the estimated total burden in each category, according to new estimates from the Centers for Disease Control and Prevention (CDC).

Jan 19, 2012

Jan 19, 2012

Review renews questions about oseltamivir benefits

(CIDRAP News) – A lengthy new analysis of unpublished clinical trial data is renewing questions about the effectiveness of the influenza drug oseltamivir (Tamiflu), saying that although the drug shortens flu symptoms by about a day, there is no evidence that it reduces hospital admissions.

Oct 22, 2009

Oct 22, 2009

CDC notes change in ethnic pattern of H1N1 impact

(CIDRAP News) – The Centers for Disease Control (CDC) has seen a change in the ethnic distribution of fatal pandemic H1N1 influenza cases, a CDC official reported at a meeting of its vaccine advisory committee today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 25, 2007

Oct 25, 2007

THE PANDEMIC VACCINE PUZZLE Bibliography

Editor's note: This is the bibliography to a seven-part series launched October 25, 2007, investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»